Diamines & Chemicals Ltd-$
We submit herewith Unaudited Financial Results for the Quarter ended June 30,2026
RESULTS
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 05 Aug 2026, 01:28 PM IST · BSE ID: a2a402d6-7b9d-47b5-8a32-de65fa49143f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported its first quarter financial results, decided to invest Rs. 40 Crores in a subsidiary, and halted a non-performing business segment.
🤖 AI Summary
- Board approved Q1 FY27 Standalone and Consolidated Unaudited Financial Results for period ended June 30, 2026.
- Approved additional investment of Rs. 40 Crores in wholly-owned subsidiary for capital/operational expenditure.
- Current project achieved substantial completion, but commercial production not commenced due to distillation process optimization.
- Allotted 2,127 equity shares of Rs. 10/- each to employees, increasing paid-up capital to Rs. 10,05,55,190/-.
- Discontinued Trading Division in farming industry (Fruits & Vegetables segment) with immediate effect.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operations (Q1 FY27)
1,436.85 Lakhs
Standalone Revenue from Operations (Q1 FY26)
1,222.95 Lakhs
Standalone Profit before Tax (Q1 FY27)
27.32 Lakhs
Additional Investment in Wholly Owned Subsidiary
40 Crores
Paid-up Equity Share Capital after allotment
Rs. 10,05,55,190/-
🏢 How This Affects the Company
Discontinuation of the Trading Division in farming industry streamlines operations by removing a non-contributing segment, as no business was generated in this segment since last year. Focus shifts entirely to Speciality Chemicals, potentially improving resource allocation.
The approved additional investment of Rs. 40 Crores in the wholly-owned subsidiary, to be met from cash accruals and liquid funds, impacts the balance sheet by deploying cash reserves for future capital/operational expenditures. This could affect the company's liquidity position in the short term, but aims for long-term growth.
The current project, despite substantial completion, has not commenced commercial production due to ongoing optimization of the distillation process, indicating a delay in realizing potential operational benefits and revenue from the new facility. The discontinuation of the Trading Division simplifies operational overheads.
The delay in commercial production for the current project introduces an operational risk regarding time-to-market and realization of investment returns for the new facility. The investment in the subsidiary, while from internal accruals, commits a significant sum before the main project's commercialization.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
Shareholders will see a minor dilution effect from the allotment of 2,127 equity shares, increasing the total paid-up equity shares from 1,00,53,392 to 1,00,55,519 shares.
🔍
Management Signal
Management is signaling a strategic focus on the core Speciality Chemicals business by discontinuing a non-performing segment and investing in the subsidiary, while working through project commissioning challenges.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor progress on project commercial production.
Updates on distillation process optimization and commercial production commencement.
Details of subsidiary investment deployment and its impact on cash flows.
MEDIUM RISK
Project commissioning delays and significant decline in core segment profit before tax are noted.
💡 Investor Takeaway
Diamines & Chemicals reported Q1 FY27 Standalone Revenue from Operations of Rs. 1,436.85 Lakhs, up from Rs. 1,222.95 Lakhs YoY. Profit before tax for Q1 FY27 was Rs. 27.32 Lakhs. An additional Rs. 40 Crores investment in the wholly-owned subsidiary from cash accruals was approved. Commercial production for the new project is pending distillation process optimization.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Revenue from Operations for Q1 FY27 increased to Rs. 1,436.85 Lakhs from Rs. 1,222.95 Lakhs in Q1 FY26.
- The company demonstrated internal capital generation with an approval to invest Rs. 40 Crores in its wholly-owned subsidiary from cash accruals and liquid funds.
⚠️ Concerns
- Profit before Tax for Q1 FY27 was Rs. 27.32 Lakhs, significantly lower than the Rs. 98.14 Lakhs reported for the Speciality Chemicals segment in Q1 FY26.
- Commercial production for the new project has not yet commenced due to ongoing optimization of the distillation process, delaying expected revenue streams.
📅 Company Track Record
Diamines & Chemicals Ltd's Board meeting on August 05, 2026, was previously intimated on July 21, 2026, specifically to approve the Q1 FY27 Un-audited Financial Results. This filing details the outcomes of that scheduled meeting, including the financial results and other strategic decisions.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What were Diamines & Chemicals Ltd's standalone revenues for Q1 FY27?
Diamines & Chemicals Ltd reported Standalone Revenue from Operations of Rs. 1,436.85 Lakhs for the quarter ended June 30, 2026 (Q1 FY27).
What was the Profit before Tax for Diamines & Chemicals Ltd in Q1 FY27?
The Standalone Profit before Tax for Diamines & Chemicals Ltd was Rs. 27.32 Lakhs for the quarter ended June 30, 2026.
What additional investment was approved for the wholly-owned subsidiary?
An additional investment of Rs. 40 Crores was approved for the wholly-owned subsidiary, to be met out of cash accruals and other liquid funds.
Has commercial production commenced for the company's current project?
Commercial production for the current project has not yet commenced due to the ongoing optimization of the distillation process, despite substantial completion of other aspects.
What was the paid-up equity share capital of Diamines & Chemicals Ltd after the employee share allotment?
Upon allotment of 2,127 equity shares, the paid-up equity share capital of the Company increased to Rs. 10,05,55,190/- divided into 1,00,55,519 equity shares of Rs. 10/- each.
Questions based on this BSE filing only. For information purposes.